FDA recall D-0790-2020

Lupin Pharmaceuticals Inc. · Class III · drug

Product

Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215mg/0.025 mg and 0.250 mg/0.025 mg, Pack size - 3 x 28's wallets/carton, Rx Only, Distributed by Lupin Pharmaceuticals, Inc, Baltimore MD 21202, Manufactured by: Lupin Limited, Pithampur, (M.P.)- 454775, India. NDC 68180-837-13 (3x28 carton ) NDC 68180-837-11 (28 tablet wallet)

Reason for recall

CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data.

Distribution

Distributed nationwide in the US

Key facts

Status
Terminated
Initiation date
2020-01-10
Report date
2020-01-22
Termination date
2021-06-03
Voluntary/Mandated
Voluntary: Firm initiated
Location
Baltimore, MD, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0790-2020